Evolus (EOLS) Research & Development (2017 - 2026)
Evolus' (EOLS) quarterly Research & Development came in at $2.2 million in Q1 2026, up 1.27% YoY from $2.2 million in Q1 2025, and down 35.65% on a QoQ basis from $3.5 million in Q4 2025.
Evolus (EOLS) Research & Development (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Research & Development data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Research & Development rose 1.27% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.6 million (up 3.2% YoY) and the FY2025 annual result came in at $9.6 million, up 4.4% from the prior year.
- Research & Development fell to $2.2 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $3.5 million in Q4 2025 to a low of $468000.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $2.0 million in 2025 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 357.14% in 2022, down 44.35% in 2022.
- Tracing EOLS's Research & Development over 5 years: stood at $1.3 million in 2022, then surged by 76.56% to $2.4 million in 2023, then advanced by 2.1% to $2.4 million in 2024, then soared by 43.25% to $3.5 million in 2025, then slumped by 35.65% to $2.2 million in 2026.
- The last three Research & Development figures came in at $2.2 million (Q1 2026), $3.5 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 549.85 Mn | 504.68 Mn | 57.18 Mn | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Mn |
| Mar 31, 2026 | 2.24 Mn |
| Dec 31, 2025 | 3.48 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.38 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 468,000.00 |
| Dec 31, 2021 | 423,000.00 |
| Sep 30, 2021 | 301,000.00 |